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Abstract In epithelial and endothelial cells, tight junctions lim-
it paracellular £ux of ions, proteins and other macromolecules.
However, mechanisms regulating tight junction function are not
clear. Occludin, a tight junction protein, undergoes phosphory-
lation changes in several situations but little is known about
occludin kinases. A recombinant C-terminal fragment of occlu-
din is a substrate for a kinase in crude extracts of brain. This
activity was puri¢ed about 10 000-fold and identi¢ed as CK2
(casein kinase 2) by peptide mass ¢ngerprinting, immunoblotting
and mutation of CK2 sites within the occludin sequence. CK2 is
therefore a candidate kinase for regulation of occludin phos-
phorylation in vivo.
+ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Endothelial and epithelial cells are coupled via intercellular
junctions [1]. Tight junctions limit the £ux of ions, proteins
and other macromolecules via the paracellular pathway. They
also polarize cells into apical and basolateral domains [2]. The
protein composition and molecular architecture of tight junc-
tions are being discovered. Peripheral cytoplasmic proteins,
such as ZO-1 [3], interact with membrane-spanning proteins,
such as occludin and claudins [2,4^6]. Mechanisms underlying
the variability and regulation of the permeability properties of
epithelial and endothelial cells remain to be established. These
may play a role in tight junction breakdown occurring in
in£ammatory and hypoxic disorders.
In terms of regulation, phosphorylation of tight junction
components, especially occludin, has been reported but the
identity of the regulatory kinases and signalling pathways is
still under investigation. In Madin^Darby canine kidney
(MDCK) cells, calcium stimulates tight junction formation
and, concomitantly, occludin becomes phosphorylated on ser-
ine and threonine residues [7,8]. In retinal endothelial cells,
vascular endothelial growth factor stimulates occludin phos-
phorylation, perhaps playing a role in diabetic retinopathy [9].
In early development, occludin appears to undergo dephos-
phorylation and various pre-puri¢ed kinases, including casein
kinase 2 (CK2) and cdc2, were proposed to phosphorylate
occludin [10,11]. Protein kinase C (PKC) has also been sug-
gested as an occludin kinase [12] or to regulate occludin phos-
phorylation in other ways [13]. Other studies link occludin
phosphorylation with shear stress [14] and tight junction re-
assembly following cellular adenosine triphosphate (ATP) de-
pletion [15]. Tyrosine kinases [16] and G-protein-coupled re-
ceptor-activated pathways involving rho-regulated signalling
[17] have also been implicated in regulation of occludin phos-
phorylation.
Clearly, occludin phosphorylation is a real phenomenon
and various kinases have been proposed as occludin kinases.
Some approaches involved incubation of recombinant frag-
ments of occludin with known kinases, and their physiological
relevance must be questioned. We adopted the unbiased ap-
proach of incubating occludin fragments with tissue or cell
extracts where kinase activity may be expected to be low
and physiologically signi¢cant. Occludin phosphorylating ac-
tivity was detected. This was puri¢ed and identi¢ed. The re-
sults are presented below.
2. Materials and methods
2.1. Materials
Suppliers of materials were: Amersham: [Q-33P]ATP, Amplify,
Rainbow markers, HiTrap columns, fast protein liquid chromatogra-
phy (FPLC) systems, horseradish peroxidase (HRP)-conjugated anti-
mouse IgG antibody; Calbiochem: Brij-35, 1,2-bis(o-aminophenoxy)-
ethane-N,N,NP,NP-tetraacetic acid (BAPTA); Invitrogen: colloidal
blue and silver quest staining kits; Pierce: bicinchoninic acid (BCA)
protein assay reagents; BD Transduction Laboratories: CK2L and
CK2K/KP mouse monoclonal antibodies. Porcine brains were fresh
from an abattoir, immediately snap frozen on dry ice for transport
and then stored at 380‡C. ECV304 cells were cultured as described
[17].
2.2. Bu¡ers
Bu¡er A: 20 mM HEPES/NaOH, 1 mM ethyleneglycol-bis-(L-ami-
noethylether)-N,N,NP,NP-tetraacetic acid (EGTA), 0.03% (v/v) Brij-35,
0.1 mM phenylmethylsulfonyl £uoride (PMSF), 1 mM benzamidine,
1 Wg/ml aprotinin and 1 Wg/ml leupeptin. Bu¡er B: Bu¡er A contain-
ing 1 M NaCl. Bu¡er C: Bu¡er A containing 150 mM NaCl. The ¢nal
pH of the bu¡ers was 8.0 at 4‡C.
2.3. Glutathione-S-transferase (GST)-occludin and mutagenesis
GST was fused to residues 264^521 of mouse occludin [4], and this
resulted in a linker sequence (LVPRGSPEF). Mutagenesis (Quick-
Change kit, Stratagene) created either amino acid substitutions or,
to truncate protein, stop codons. Plasmids from XL1-blue supercom-
petent cultures were puri¢ed (Qiagen midiprep system) and mutagen-
esis was con¢rmed by DNA sequence analysis. BL21 cells were trans-
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formed and cultures were induced with 1 mM isopropyl thiogalactose
(IPTG) for 2 h at 37‡C. Cells were solubilized in phosphate-bu¡ered
saline (PBS) containing 1.5% sarcosyl [18], 1 mM ethylenediamine
tetraacetic acid (EDTA), 1 mM PMSF, 10 Wg/ml leupeptin, 10 Wg/
ml soybean trypsin inhibitor and 0.1 U/ml K2-macroglobulin. After
sonication on ice, insoluble material was removed by centrifugation.
The supernatant was passed through a glutathione Sepharose column.
After washing with PBS, fusion proteins were eluted in 50 mM Tris/
HCl containing 10 mM reduced glutathione (pH 8.0). Fractions were
analyzed for protein and dialyzed before use.
2.4. Kinase puri¢cation
Porcine brain was fragmented in N2 (l) using a pestle and mortar. A
Waring blender was used to extract the tissue into ice-cold bu¡er (1 g
tissue: 2.5 ml bu¡er) containing 20 mM HEPES/10 mM NaOH, 5 mM
EDTA, 0.1 mM vanadate, 1% Triton X-100, 0.1 mM PMSF, 1 mM
benzamidine, 10 Wg/ml aprotinin, and 10 Wg/ml leupeptin. After cen-
trifugation for 1 h at 100 000Ug, the supernatant was ¢ltered through
60 Wm and 0.2 Wm ¢lters and used immediately. The extract was
applied at 5 ml/min onto a 5 ml SP-Sepharose HP column equilibrat-
ed in Bu¡er A. After washing in Bu¡er A until A280 had reached
background, kinase activity was eluted using a step gradient of 50%
Bu¡er B, collecting 5 ml fractions. Active fractions were pooled, di-
luted 4-fold in Bu¡er A and applied to a 5 ml Q-Sepharose HP
column equilibrated in Bu¡er A. The column was developed with a
100 ml linear gradient of NaCl to 1 M at a £ow rate of 5 ml/min,
collecting 5 ml fractions. Active fractions were pooled, diluted 4-fold
in Bu¡er A and applied to a 1 ml Q-Sepharose HP column equili-
brated in Bu¡er A. A step gradient to 1 M NaCl was applied at a £ow
rate of 1 ml/min and 0.5 ml fractions were collected. Active fractions
were further concentrated to 50 Wl in a Microcon 10 spin ¢lter unit
(Anachem) and loaded onto a Superdex-200 PC 3.2/30 column at
40 Wl/min in Bu¡er C, collecting 150 Wl fractions. Active fractions
were pooled, diluted to 1 ml in Bu¡er A and chromatographed on
a 1 ml heparin HP column equilibrated in 50% Bu¡er B. The column
was developed with a 10 ml linear gradient to 1 M NaCl at a £ow rate
of 1 ml/min, collecting 1 ml fractions. Proteins in the fractions were
resolved by sodium dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) (10% gels) and visualized by silver staining or, after
transfer to nitrocellulose, by immunoblotting (see [17,19]). For mass
spectrometry, protein in the entire fraction was precipitated [20], re-
solved by SDS^PAGE and stained with colloidal blue.
2.5. Kinase assay
Aliquots (5 Wl) of extracts or fractions were assayed in a volume of
50 Wl in the absence or presence of 1 Wg GST-occludin. Bu¡er con-
tained 50 mM L-glycerophosphate, 25 mM HEPES, 12.5 mM NaOH,
0.1 mM Na3VO4, 10 mM MgCl2, 2 mM BAPTA, 0.1 mM ATP and
0.37 MBq [Q-33P]ATP, pH was 7.4 at 37‡C. Reactions were at 37‡C
for 20 min and quenched by addition of 12.5 Wl boiling hot 10% SDS
in 50% glycerol/0.01% bromophenol blue. Samples were resolved by
SDS^PAGE [21], ¢xed, stained with Coomassie blue (R250), impreg-
nated with Amplify, dried and exposed to ¢lm at 380‡C. Quantitation
was by phosphorimaging using [33P]phosphoprotein standards. Phos-
phoamino acid analysis was according to Boyle et al. [22].
2.6. Peptide mass ¢ngerprinting
In-gel digestion of proteins was performed by established methods
[23]. Brie£y, gel slices containing bands were cut into 1 mm3 pieces,
washed with 25 mM NH4HCO3 in 50% acetonitrile, reduced with
dithiothreitol (10 mM, 56‡C, 30 min) and S-alkylated with 55 mM
iodoacetamide (45 min in the dark). The gel pieces were washed twice
with 50 mM NH4HCO3 in 50% acetonitrile and, to dehydrate, once in
100% acetonitrile. Sequencing grade modi¢ed trypsin (Promega, 20 Wg)
was reconstituted in 200 Wl of 1 mM HCl then diluted 8-fold in 50 mM
NH4HCO3. Gel pieces were rehydrated in trypsin solution for 45 min
on ice. Excess solution was removed and replaced with bu¡er. Sam-
ples were then incubated overnight at 37‡C and then extracted two or
three times in 5% tri£uoroacetic acid/50% acetonitrile and once in
100% acetonitrile. Supernatants were pooled, dried in a Speed Vac
and then resuspended in 10^30 Wl of 0.1% tri£uoroacetic acid (TFA)
containing 1^10% acetonitrile.
The masses of tryptic peptides were determined by matrix-assisted
laser desorption/ionization-time-of-£ight (MALDI-TOF) on a Bruker
REFLEX instrument. A small portion of the digest (V0.5 Wl) was
spotted onto a thin layer of K-cyano-4-hydroxycinnamic acid (twice-
recrystallized; Sigma)/nitrocellulose previously deposited from solu-
tions in acetone (three parts 20 mg/ml matrix: one part 10 mg/ml
nitrocellulose; 0.5 Wl applied). Spectra were obtained by summing at
least 150 individual laser shots. The masses obtained were then en-
tered into the MASCOT search engine (www.matrixscience.com, [24];
parameters: error S 0.35 Da; one missed cleavage allowed; mamma-
lian database searched).
3. Results and discussion
3.1. An occludin phosphorylating activity is detected in
brain extracts
Occludin spans the plasma membrane four times [4,5]. This
Table 1
Puri¢cation of an occlusion kinase from porcine brain
Step Volume (ml) Protein (mg) Activity (U) Speci¢c activity (U mg31) Puri¢cation (fold) Yield (%)
1. Extract 23 395 33.4 0.084 ^ ^
2. SP-Sepharose 25 39.3 241 6.132 1 100
3. Q-Sepharose 10 5.4 464 85.9 14 193
4. Superdex-200 0.45 0.78 66.6 85.3 13 27.6
5. Heparin-Sepharose 3 0.001 54.0 54 000 8806 22.4
The amount of brain used in this preparation was 20 g. A unit is de¢ned as pmol of phosphorylated GST-occludin produced in a 20 min reac-
tion. Protein for Steps 1^3 was determined by the BCA method. A280 was used to estimate the protein in Steps 4 and 5.
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Fig. 1. An occludin kinase activity is detectable in brain extracts.
A: Brain extracts and puri¢ed GST-occludin264521 were incubated
either alone or together in the presence of kinase assay bu¡er. Pro-
teins were analyzed by SDS^PAGE and stained with Coomassie
blue. The migration of GST-occludin is indicated. B: The corre-
sponding autoradiogram of A. C: Phosphoamino acid analysis of
phosphorylated GST-occludin.
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results in three regions of the protein having access to the
cytoplasm, and which therefore could be accessible to kinases
for phosphorylation. The N-terminal region (murine se-
quence) is composed of about 66 residues. Transmembrane
regions two and three are linked by residues 159^168. The
C-terminal region extends from residues 264^521. GST fused
to N- or C-terminal regions was prepared and a peptide cor-
responding to the linker region was synthesized. These were
then tested as potential kinase substrates in extracts of brain
tissue. Reactions were set up and analyzed. The staining of
proteins from brain extracts shows many stained bands, as
expected (Fig. 1A). GST-occludin264521 migrates as an ob-
vious 64 kDa protein, even when incubated with brain ex-
tracts (Fig. 1A). The autoradiogram (Fig. 1B) shows many
phosphoproteins produced by incubation of brain extracts
with ATP. GST-occludin is phosphorylated in the presence
but not absence of brain extract. Therefore, kinase activity
is present in brain extract that is capable of phosphorylating
residues within GST-occludin264521. Control experiments (see
later) show that this phosphorylation is within the occludin
residues. Other experiments (results not shown) using either
GST-occludin166 or peptide containing residues 159^168 as
substrates did not show phosphorylation in incubations with
brain extract. Phosphoamino acid analysis (Fig. 1C) of phos-
phorylated GST-occludin264521 revealed mainly phosphoser-
ine and some phosphothreonine. Phosphotyrosine was not
detectable.
3.2. Puri¢cation of the occludin phosphorylating activity
The occludin phosphorylating activity was puri¢ed (Table
1). Extract was applied to a cation exchange column and
eluted using a step gradient. About 90% of bulk protein was
lost at this point. Fractions containing activity were diluted
and applied to an anion exchange column. Occludin phos-
phorylating activity eluted at about 0.4 M NaCl. This fraction
was concentrated and applied to a gel ¢ltration column
(Superdex-200) and activity eluted between ferritin (440
kDa) and aldolase (158 kDa) standards. The heparin step
gave signi¢cant puri¢cation. Most protein in the sample at
this stage was eluted with 6 0.5 M NaCl. However, the oc-
cludin phosphorylating activity had high a⁄nity for heparin
and eluted at about 0.7 M NaCl. At this point, protein was
just detectable by ultraviolet (UV) absorbance. Quantitation
showed puri¢cation of about 10 000-fold with a yield of ap-
proximately 20%.
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Fig. 2. Fractionation of kinase activity using heparin-Sepharose. Ac-
tivity phosphorylating occludin was puri¢ed up to Step 4 as de-
scribed in Table 1. Protein was then fractionated using heparin-Se-
pharose, employing a 0.5^1.0 M salt gradient. The gradient is based
on conductivity measurements. A: Elution pro¢le of GST-occludin
phosphorylating activity (¢lled circles) with salt gradient. In the ab-
sence of GST-occludin (open circles), phosphorylating activity was
not detected. B: Phosphorylation of GST-occludin. C: Coomassie
stain of GST-occludin. D: Fractions were analyzed by SDS^PAGE
and silver staining. Arrows indicate bands of 41 and 26 kDa.
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Fig. 3. Phosphorylation site analysis. Truncated and mutant forms
of GST-occludin were analyzed for their ability to be phosphorylat-
ed. The kinase was puri¢ed as described in Table 1. Upper panels
show Coomassie staining of substrates; lower panels, the corre-
sponding autoradiograms. GST was fused to parts of occludin as
follows: WT (264^521), residues 264^521; S338A, as WT (264^521)
but serine 338 mutated to alanine; WT (264^327), residues 264^327;
WT (264^439), residues 264^439; GST+linker, GST fused to linker
sequence found in all GST-occludin variants; S407A, as WT (264^
521) but serine 407 mutated to alanine; T403A, as WT (264^521)
but threonine 403 mutated to alanine; T403A/S407A, a double mu-
tant of WT (264^521).
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Quantitation (Fig. 2A) of phosphorylating activity (Fig. 2B)
eluting from the heparin column using equal amounts of
GST-occludin (Fig. 2C) shows a peak in fraction 7. Fractions
were analyzed by SDS^PAGE and silver staining to reveal
two bands of 41 and 26 kDa that also peaked in fraction 7
(Fig. 2D). As the 41 and 26 kDa bands were the only ones co-
eluting with the occludin kinase activity at a stage when pu-
ri¢cation was substantial, they were analyzed further.
3.3. Identi¢cation of the occludin phosphorylating activity
Protein in the entire fractions was quantitatively precipi-
tated and resolved by SDS^PAGE and stained with colloidal
Coomassie to reveal the same 41 and 26 kDa bands. In addi-
tion, a band of 44 kDa was observed (result not shown) that
also co-eluted with activity. The three proteins were subjected
to tryptic peptide mass mapping. In all cases, good sequence
coverage was obtained and MOWSE scores were signi¢cant
(Table 2). The data identify the three proteins as subunits of
CK2. CK2 is highly conserved across species ; K/KP subunits
are catalytically active and the L subunits serve a regulatory
role [25].
3.4. Occludin mutagenesis and CK2 sites
Analysis of GST-occludin phosphorylation was performed
(Fig. 3). Puri¢ed kinase (Table 1) was incubated with a variety
of forms of the protein. Mutation of serine 338, a site for
phosphorylation by PKC [12], to alanine (S338A) did not
have any e¡ect on phosphorylation. Removal of the last 194
residues (wild-type (WT) (264^327)) or the entire occludin
sequence (GST+linker) prevented phosphorylation, whereas
removal of the last 82 residues (WT (264^439)) had no e¡ect.
Therefore, phosphorylatable residues lie between amino acids
328 and 439. The minimum consensus sequence for CK2 is [S/
T-X-X-D/E], and further negatively charged residues at posi-
tions 31 to +7 enhance CK2 phosphorylation [11]. Residues
serine 407 (31 to +7: ESCEELEED) and threonine 403 (31
to +7: TTGGESCEE), as suggested previously [11], are good
candidates for CK2 sites within the region of interest within
occludin. Mutagenesis of serine 407 to alanine resulted in
reduced ability of the kinase to phosphorylate occludin. The
threonine 403 to alanine mutant had a smaller e¡ect but the
double mutant (T403/S407A) was even less phosphorylated
than either of the single mutants. These data are consistent
with the claim that CK2 is the kinase in brain extracts respon-
sible for phosphorylation of occludin.
3.5. Co-elution of CK2 with occludin phosphorylating activity
in extracts of ECV304 cells
Brain tissue is a convenient starting point for kinase puri-
¢cation. However, the observations on occludin phosphoryla-
tion that were of interest to us were made using ECV304 cells
[17]. The possibility that CK2 was responsible for occludin
phosphorylation in extracts of these cells was investigated.
As CK2 has a distinctive chromatographic pro¢le on heparin
columns, fractionation of ECV304 cell extracts was performed
and showed activity eluting at about 0.7 M NaCl (Fig. 4A, B),
as with extracts of brain. Equal use and loading of GST-oc-
cludin was veri¢ed (Fig. 4C). Immunoblot analysis of the
fractions showed co-elution of activity with the L (27 kDa,
Fig. 4D) and K/KP subunits of CK2 (V44 kDa, Fig. 4E).
Table 2
Peptide mass ¢ngerprint identi¢cation of protein bands as CK2 subunits
Protein (i.d.) Observed MHþ Expected MHþ Delta
26 kDa (CK2L) 2007.71 2007.82 30.11
1687.63 1687.85 30.22
1390.54 1390.58 30.04
1084.69 1084.59 0.10
41 kDa (CK2K) 1864.87 1864.85 0.02
1798.93 1798.85 0.08
1771.99 1771.88 0.11
1524.92 1524.80 0.12
1449.93 1449.79 0.14
1331.78 1331.61 0.17
1106.89 1106.55 0.34
1050.83 1050.55 0.28
44 kDa (CK2KP) 1873.58 1873.85 30.27
1770.66 1770.85 30.19
1742.63 1742.83 30.20
1731.71 1731.86 30.15
1726.59 1726.84 30.25
1622.60 1622.68 30.08
1613.62 1613.76 30.14
1606.58 1606.69 30.11
1590.54 1590.69 30.15
1565.66 1565.66 0.00
1549.66 1549.66 0.00
1528.68 1528.76 30.08
1357.68 1357.69 30.01
1310.81 1310.76 0.05
1122.70 1122.79 30.09
1106.71 1106.55 0.16
1019.68 1019.51 0.17
The 26 kDa protein gave seven peaks of which four matched those expected of the CK2L subunit, giving 23% sequence coverage and a
MOWSE score of 80. The 41 kDa protein gave eight matched peaks out of 10 accounting for 27% coverage of protein identi¢ed as CK2K sub-
unit and a MOWSE score of 105. The 44 kDa protein gave 28 mass peaks of which 17 matched sequences in the CK2KP subunit accounting
for 38% coverage and giving a MOWSE score of 124.
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These data strongly support the notion that CK2 is also an
occludin kinase in ECV304 cells.
3.6. Conclusions
Much evidence indicates that occludin is a substrate for
kinase(s) in a variety of model systems (see Section 1).
Some studies describe occludin phosphorylation changes tak-
ing place in di¡erent situations. Others attempted to identify
occludin kinases. One approach involves incubation of re-
combinant fragments of occludin with pre-puri¢ed and known
kinases. Our approach was unbiased and was to examine if
any occludin phosphorylating activity existed in extracts of
tissue. In these experiments, the concentration of kinase
would be expected to be much lower raising the possibility
of physiological relevance. Activity was detected and its puri-
¢cation and characterization revealed it to be CK2. Pre-puri-
¢ed CK2 was also reported to phosphorylate Xenopus laevis
occludin in vitro [10,11]. The in vivo relevance of CK2 as an
occludin kinase should be now examined. Also, observations
implicating other serine/threonine kinases, such as PKC [12],
and the tyrosine kinase c-Yes [16] as occludin kinases need to
be considered when examining the physiological and patho-
logical relevance of occludin phosphorylation.
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